Abstract
During Ca2+ activation, the Ca2+-binding sites of C2 domains typically bind multiple Ca2+ ions in close proximity. These binding events exhibit positive cooperativity, despite the strong charge repulsion between the adjacent divalent cations. Using both experimental and computational approaches, the present study probes the detailed mechanisms of Ca2+ activation and positive cooperativity for the C2 domain of cytosolic phospholipase A2, which binds two Ca2+ ions in sites I and II, separated by only 4.1 Å. First, each of the five coordinating side chains in the Ca2+-binding cleft is individually mutated and the effect on Ca2+-binding affinity and cooperativity is measured. The results identify Asp 43 as the major contributor to Ca2+ affinity, while the two coordinating side chains that provide bridging coordination to both Ca2+ ions, Asp 43 and Asp 40, are observed to make the largest contributions to positive cooperativity. Electrostatic calculations reveal that Asp 43 possesses the highest pseudo-pKa of the coordinating acidic residues, as well as the highest general cation affinity, due to its relatively buried location within 3.5 Å of seven protein oxygens with full or partial negative charges. These calculations therefore explain the greater importance of Asp 43 in defining the Ca2+ affinity. Overall, the experimental and computational results support an activation model in which the first Ca2+ ion binds usually to site I, thereby preordering both bridging side chains Asp 40 and 43, and partially or fully deprotonating the three coordinating Asp residues. This initial binding event prepares the conformation and protonation state of the remaining site for Ca2+ binding, enabling the second Ca2+ ion to bind with higher affinity than the first as required for positive cooperativity.
The C2 domain is a ubiquitous membrane-targeting protein module found in a diverse array of signal transducing proteins that regulate key cellular processes at membrane surfaces (reviewed in refs 1–10). These processes include the generation of lipid-derived second messengers, vesicular targetting and fusion, GTPase regulation, protein phosphorylation, pore formation by cytolytic T cells, and ubiquitin-mediated protein degradation. The majority of C2 domains are activated by cytoplasmic Ca2+ signals and dock to specific membrane-associated targets such as phospholipids or, less commonly, to membrane-bound proteins.
The structures of representative Ca2+-regulated C2 domains, including the C2A domain of synaptotagmin I (Syt-IA),1 the C2 domain of cytosolic phospholipase A2 (α-isoform, cPLA2α), and the C2 domain of protein kinase C (PKC), have been determined by X-ray crystallography or NMR spectroscopy (11–16). These C2 domains are divided into two distinct topological classes termed Types I and II which share the same β-sandwich architecture but differ by a circular permutation in their pattern of β-strand connectivities (7). At one edge of the β-sandwich two or more Ca2+ ions bind with positive cooperativity in a cleft formed by three interstrand loops and lined with Ca2+-coordinating side chains. These Ca2+-binding loops are termed CBL I–III in order of their sequence in the primary structure. Together they provide Ca2+ coordination for up to four potential Ca2+-binding sites labeled sites I–IV; however, in a given C2 domain only a subset of the four sites may actually bind Ca2+ in solution, since not all the sites provide adequate Ca2+ coordination. Thus, the Ca2+-loaded C2 domains characterized to date possess from one to three Ca2+ bound in different combinations of sites I–IV (12, 15, 17–19).
The present study focuses on the C2 domain of cPLA2α, which upon Ca2+ activation docks to neutral lipids on the surface of specific intracellular membranes (6, 20, 21). Following docking, the separate catalytic domain hydrolytically releases arachidonic acid from lipid substrates, thereby triggering a variety of pathways including the inflammation response targeted by common anti-inflammatory drugs (22, 23). The isolated cPLA2α C2 domain is activated by the binding of two Ca2+ ions in solution with positive cooperativity, and this activation dramatically increases the affinity of the domain for membrane docking (18). High-resolution structures of the free domain reveal that the two bound Ca2+ ions occupy sites I and II of the four potential sites (15, 24), but it is not known which of the two sites are loaded first during the activation process, and much remains to be learned about the mechanism of positive cooperativity for C2 domains in general. Such positive cooperativity is quite a remarkable feature of C2 domains, since these proteins typically bind multiple Ca2+ ions in close proximity where charge repulsion between the bound divalent cations is formidable. The existence of positive cooperativity indicates that despite this mutual repulsion the last Ca2+ ions bind more tightly than the first Ca2+ ion.
The only C2 domain for which a careful study of the order of Ca2+ binding has been undertaken is the C2A domain of synaptotagmin I, which binds three Ca2+ ions. NMR analysis of a Ca2+ titration revealed evidence that site I loads first with Ca2+, followed by site II, and finally site III (19). (Note that it is coincidental that the order of binding follows the same sequence as the prior numbering of Ca2+-binding sites in the structure). However, since different C2 domains utilize different combinations of sites I–IV to bind different numbers of Ca2+ ions, it is not yet clear whether the Ca2+-binding order observed for the synaptotagmin C2A domain is relevant for other C2 domains. Moreover, no systematic study has yet tested the importance of specific coordinating side chains in the mechanism of positive cooperativity, although it has been suggested that bidentate aspartate side chains which simultaneously coordinate two Ca2+ ions could play a role in cooperativity between sites (19, 24). To investigate the role of specific coordinating side chains in the Ca2+-binding pocket of the cPLA2α C2 domain, each of the five coordinating side chains has been substituted to eliminate its contribution to Ca2+ coordination. The effects of these substitutions on the affinity and cooperativity of Ca2+ binding have been quantitated using a fluorescence method to monitor the binding of two Ca2+ ions to the isolated C2 domain in solution. The results reveal the order of Ca2+ binding to the two sites, and indicate that Asp 43 is the most critical Ca2+ coordinating residue. In addition, computational analysis of pseudo-pKa values for the three coordinating aspartate residues reveal that the negative charge of Asp 43 is highly destabilized by its local environment, which explains the central importance of this residue to Ca2+ affinity. Finally, the results indicate that the bridging residues Asp 40 and 43, which each coordinate both Ca2+ ions, are essential for positive cooperativity between the two Ca2+ sites. A molecular model based on both the experimental and computational findings is proposed to explain the importance of these bridging ligands to positive cooperativity.
METHODS
Protein Mutagenesis, Expression, and Purification
Single Cys mutants of the human cPLA2α C2 domain (residues 1–138) were generated using the single-stranded mutagenesis technique of Kunkel et al. as previously described (25, 26). Cys mutants were expressed as inclusion bodies in Escherichia coli, then were isolated, denatured, and refolded (26). Following refolding, each mutant was purified by FPLC size exclusion on a Superdex G-75 gel filtration column in purification buffer containing 100 mM KCl, 20 mM Tris pH 7.8 with HCl, and 1 mM CaCl2. Analysis by polyacryl-amide gel electrophoresis (PAGE) indicated that each mutant was at least 95% pure. Protein was snap-frozen in liquid N2 and stored at −80 °C. Finally, immediately prior to Ca2+ affinity measurements, the protein was loaded onto a Chelex-100 resin column equilibrated with standard assay buffer containing 100 mM KCl, 20 mM N-(2-hydroxyethyl)-piperazine-N′-2-ethanesulfonic acid (HEPES), pH 7.4 with KOH. Passage over this column removed all bound and free Ca2+ from the protein sample, and replaced the purification buffer with standard assay buffer (18). The residual contaminating Ca2+ concentration is submicromolar (18).
Fluorescence Measurement of Ca2+ Binding
Equilibrium fluorescence experiments were carried out on a Photon Technology International QM-2000-6SE Fluorescence spectrometer at 25 °C. The intrinsic tryptophan fluorescence of Trp71 was monitored using excitation and emission wavelengths of λex = 284 nm and λem = 320 nm, with excitation and emission slit width settings of 4 and 8 nm, respectively. A concentrated Ca2+ stock solution was titrated into the sample, generating an increase in the intrinsic Trp fluorescence as Ca2+ occupied its binding site (18). Samples contained 1.0 μM C2 domain in standard assay buffer as well as 5 mM dithiothreitol (DTT, ensuring that each mutant Cys residue was fully reduced).
The Ca2+ dependence of the fluorescence increase was quantified by plotting the fluorescence change (ΔF) as a function of free Ca2+ concentration ([Ca2+]) and best-fitted using a Hill equation (18):
| (1) |
where ΔFmax represents the calculated maximal fluorescence change (normalized to 1.0 to facilitate comparison of different mutant samples), H represents the Hill coefficient, and [Ca2+]1/2 represents the free Ca2+ concentration that induces half-maximal fluorescence change. Best-fitting was carried out via nonlinear least-squares analysis in Kaleidagraph 3.5 (Synergy). Each titration was repeated at least once to ensure reproducibility.
pKa Calculations: Overview
An energy minimization procedure was developed to optimize the locations of protons on Glu and Asp side chains that have two protonation sites and multiple torsion angles. This procedure optimizes proton positions based on an optimal sequence of protonation in which every successive proton is optimized in the context of the previously optimized protons. Subsequently, pKa calculations were carried out in four steps. First, the energy minimization procedure was implemented and the proton positions of all Asp and Glu residues were optimized according to the most likely sequence of protonation. Second, for the three coordinating Asp side chains in the Ca2+-binding pocket (Asp 40, 43, and 93), all possible protonation sequences were considered and the proton locations were optimized for each sequence, enabling calculation of a Boltzmann probability for each protonation sequence. Third, the pKa of each coordinating Asp side chain was calculated by comparing the electrostatic energies of its protonated and unprotonated states, taking into account interactions with other titratable groups, partial charges, dielectric boundaries, and solvent. Fourth, the pKa’s determined for individual protonation sequences were averaged by weighting the contribution of each protonation sequence according to its calculated probability.
pKa Calculations: Positioning Protons
The coordinates of the C2 domain of cPLA2α were taken from the X-ray crystallographic structure determined by Perisic, Williams and co-workers, PDB entry 1RLW (14). The missing hydrogen atoms (except the titratable protons on residues Glu and Asp) were added by globally optimizing the hydrogen-bond networks (27). Such an optimization has been shown to improve the results of a pKa calculation (28).
The side chain carboxylate of Glu or Asp offers two protonation sites. The choice of protonation site and subsequent choice of the torsion angle COH can have a pronounced effect on the results of a pKa calculation. Furthermore, these effects can be magnified if there are strong electrostatic interactions with other titratable residues. Thus, determining the optimum positions of the titratable protons is critical. To determine the optimum positions of these protons, we defined the energy of a titratable proton as follows:
| (2) |
The first term EPE is the electrostatic potential energy of the proton and the second term describes the effect of electron pairs of the carbonyl oxygen on the torsion angle of the O=C–O–H system about the C–O bond. In general, the latter term is negligible but is included for completeness. Describing the position of the proton in spherical coordinates relative to the position of a carboxylic oxygen atom, the above equation can be rewritten as:
| (3) |
where d = 1 Å is the distance between a titratable proton and its corresponding carboxylic oxygen; θ = 70.5° from an sp3 hybridization; ϕ is the torsion angle; φproton is the electrostatic potential at the position of the proton, and qproton is the charge on the proton. In this equation, the cosine function used to describe the torsion energy term has been taken from the work of Alexov & Gunner (29). The electrostatic contribution to the total energy of the proton can be determined as a function of the torsion angle by solving the Poisson–Boltzmann equation for different positions of the proton. For each proton, the final selected location in space is that with the lowest relative energy.
A simple strategy of protonating each Asp and Glu residue independently (parallel protonation) can be applied only to cases where the addition of a proton to one residue does not affect the position of the proton on another residue. For cases where the protonation of one residue affects the position of the proton of another residue, different choices of protonation sequences can be expected to generate different protonated conformers. The Ca2+-binding site of the cPLA2α C2 domain has three proximal aspartates; thus multiple protonation sequences must be considered.
The proton energy E provides an estimate of the negative charge density on and around a specific oxygen atom. The higher the local negative charge density, the more likely the oxygen is to be protonated, and the lower the proton energy E. The protonation methodology must ensure that the oxygen protonated earlier in the process is the one for which the proton has the lowest relative energy. To achieve this objective, we developed a sequential protonation methodology. As a first step in this methodology, the torsion angle dependent energy functions of protons (given by eq 3) are determined for all Asp and Glu residues in the protein. This first set of energy function calculations are performed in the absence of all titratable protons on Asp and Glu residues. The residue protonated first is the one that has the lowest total energy in the entire first set of calculations, including contributions from partial charges, dielectric boundaries, and solvent effects as well as torsion angle energy contributions. A second set of torsion angle dependent energy function calculations is then performed in the presence of the added proton. The second proton is then added to the residue that has the lowest energy in the second set of calculations. This procedure is repeated until the last residue in the protein is protonated.
This method of protonating Asp and Glu residues ensures a reasonable ordering of protonation. For the titratable residues in the binding site, Asp 40, 43, and 93, a further refinement was implemented. For these residues, all possible permutations of ordering were considered. The probability of each permutation of protonation was calculated according to the following logic. For a particular assumed order of protonation, each proton is placed in its minimum energy state in the context of previous protonations, and the free energy of adding the proton is given by the grand partition function:
| (4) |
where N is the total number of titratable residues, μ is the chemical potential of the solution, β is the temperature factor (kT)−1, and denotes the lowest energy of the titratable proton of residue xk when r residues have been protonated. The probability of the assumed order being correct is then given by the product of the probabilities of adding each successive proton. Using the partition function given by eq 4, the probability of correctness associated with a specific order (x1 → x2 → … → xN) can be easily derived as:
| (5) |
Since these probabilities map the magnitude of correctness onto the assumed orders of protonation and thereby onto different protonated conformers, they were subsequently used to weigh the pKa’s generated from using different protonated conformers.
The calculation of the electrostatic component of the proton energy for each given value of the torsion angle requires a discrete solution of the Poisson–Boltzmann equation. All these calculations were performed with the Poisson–Boltzmann equation solver of UHBD (30) using the following set of parameters: solvent dielectric constant of 80; protein dielectric constant of 2; PARSE charge-radii parameter sets (31); finest grid spacing of 0.1 Å probe radius of 1.4 Å (32); Stern layer of 2.0 Å; and an ionic strength of 100 mM.
pKa Calculations: Electrostatic Environment of the Modeled Protons
pKa calculations were performed utilizing an adaptation of the methodology embedded in the UHBD software package release 5.1 (30). The details of this methodology have been described elsewhere (33–35). In brief, the entire calculation was performed in two stages. In the first stage, we determined the free energy change associated with transferring each titratable residue from bulk solvent into its neutral protein environment. Such a free energy change includes changes in the electrostatic environment of the titratable residue arising from background protein partial charges and changes in dielectric boundaries and solvent accessibility. In the second stage, we determined interaction energies between all titratable residues. These interaction energies were then used along with the free energy changes calculated in the first stage to determine the most likely (Boltzmann weighted) partial charges of all titratable residue as a function of bulk pH. The pKa of each residue was then defined as the pH at which it had a 50% chance of being protonated. This two-stage calculation was performed for all the protonated conformers generated using sequential protonation. The probabilities associated with each conformer (calculated from eq 5) were finally used to weight the conformer pKa’s when calculating the macroscopic pKa, as reported in the text. These calculations were performed for a range of protein dielectric constants.
The calculation of pKa of all residues in a protein requires multiple solutions of the Poisson–Boltzmann equation. The following parameters were used in solving the linearized form of the equation: solvent dielectric constant of 80; ionic strength of 100 mM; Stern layer of 2.0 Å; probe radius of 1.4 Å (32); one-half the OPLS Lennard-Jones σ values for atomic radii (36); united-atom charge parameter set from CHARMm version 22.0 (Molecular Simulations Inc. Waltham, MA, 1992); and a series of four focusing finite difference grids 57 × 57 × 57, 30 × 30 × 30, 36 × 36 × 36 and 50 × 50 × 50 with spacings of 2.0, 1.0, 0.5, and 0.25 Å, respectively, centered on the titrating site of interest.
All simulations for this paper were conducted on the IA-32 Linux cluster provided by the National Center for Supercomputing Applications (NCSA), Urbana-Champaign.
RESULTS
Mutagenesis of Coordinating Side Chains
Figure 1 illustrates the regulatory Ca2+-binding cleft of the human cPLA2α C2 domain (24). The two activating Ca2+ ions occupy adjacent binding sites I and II and are coordinated by five amino acid side chains, which each provide one (monodentate) or two (bidentate) coordinating oxygens: Asp 40 (bidentate, bridging Ca2+ I and II), Asp 43 (bidentate, bridging Ca2+ I and II), Asn 65 (monodentate, Ca2+ I), Asp 93 (bidentate, Ca2+ II), and Asn 95 (monodentate, Ca2+ II). To determine the relative importance of these side chains to the overall Ca2+-binding affinity, each of the five residues was targeted for Cys substitution via site-directed mutagenesis. The Cys side chain is well-suited for the present study since it is smaller than the native coordinating Asp and Asn side chains and thus avoids steric clashes. Moreover, the Cys sulfhydryl does not coordinate Ca2+ due to its comparatively high pKa and to the negligible affinity of sulfur ligands for Ca2+ (37).
Figure 1.
Ca2+-binding cleft of the C2 domain of cytosolic phospholipase A2. (A) Shown is the crystallographically defined structure (24) of the Ca2+-occupied cleft focusing on the two Ca2+ ions (large spheres) and the residues that provide Ca2+ coordination. The indicated coordinating oxygens (red) are provided both by protein residues (stick representations) and solvent oxygens (small spheres). Of the five coordinating side chains, two (Asp 40 and 43) donate bridging side chain carboxylates that each coordinate both Ca2+ ions. (B) Same structure with the two Ca2+ ions removed and the coordinating residues remaining fixed to provide a clear view of the coordinating residues. Figures generated using PyMol (DeLano Scientific).
The D40C, D43C, N65C, D93C, and N95C mutations were incorporated into the human cPLA2α C2 domain gene by site-directed mutagenesis as previously described (26). The resulting mutant C2 domains were expressed in E. coli as inclusion bodies, then isolated, renatured, and purified by size exclusion chromatography to a level of 95% or greater for use in Ca2+-binding studies. All five mutant proteins were fully water soluble and eluted at the same position on the Sephadex G75 size exclusion column as the wild-type protein, indicating that they were properly folded and monomeric.
Effects of Coordinating Side Chain Substitutions on Ca2+ Binding to the Free Domain
The cPLA2α C2 domain possesses only one Trp residue, Trp 71, and the indole ring of this residue lies 12.6 and 12.0 Å from Ca2+-binding sites I and II, respectively (24). Ca2+ binding to these sites is known to trigger a local structural change that increases the intrinsic emission of Trp 71 by 15%. The resulting fluorescence increase has been used previously to monitor the titration of sites I and II with two Ca2+ ions, yielding a [Ca2+]1/2 of 14 ± 2 μM and a Hill coefficient of 1.7 ± 0.2 (6, 18). Since the Hill coefficient significantly exceeds 1.0, there is strong positive cooperativity between the two adjacent sites (18). The [Ca2+]1/2 and Hill coefficient measured using the fluorescence assay agree closely with the values determined by direct Ca2+ titration, validating the fluorescence method and confirming that the two binding sites contribute approximately equally to the fluorescence change (6, 18).
The present study utilizes the intrinsic Trp fluorescence assay to monitor Ca2+ binding to the five coordination mutants, yielding the titration curves summarized in Figure 2. Best-fitting of the Hill equation to these titration curves in turn yields the [Ca2+]1/2 values and Hill coefficients summarized in Table 1. Following is an analysis of the effect of each coordination site substitution on the Ca2+-binding properties of the C2 domain.
Figure 2.

Ca2+-binding profiles of mutant cPLA2α C2 domains, each possessing a single Cys substitution at each of the five coordinating side chain positions. Profiles were determined at 25 °C by monitoring the intrinsic fluorescence change of Trp 71, and then were fitted with the Hill equation (eq 1, see Methods) to determine the best-fit apparent Ca2+ concentration that yields half-maximal binding ([Ca2+]1/2) and the best-fit Hill cooperativity coefficient (H). The resulting best-fit curves are indicated as solid lines, while the best-fit parameters are summarized in Table 2. Samples contained 1 μM free C2 domain, 100 mM KCl, 20 mM HEPES pH 7.4, and 5 mM DTT.
Table 1.
Ca2+-Binding Parameters of Coordinating Side Chain Mutantsa
| mutant | [Ca2+]1/2(Cys)/[Ca2+]1/2 (WT) | Hill coefficient (H) |
|---|---|---|
| WT | 1 | 1.7 ± 0.2 |
| D40C | 21 ± 4 | 1.1 ± 0.1 |
| D43C | ≫200 | n.d. |
| N65C | 9 ± 2 | 1.4 ± 0.2 |
| D93C | 10 ± 3 | 0.8 ± 0.1 |
| N95C | 3 ± 1 | 1.8 ± 0.3 |
Ca2+ concentrations required to give half-maximal binding ([Ca2+]1/2) and Hill cooperativity coefficients were determined at 25°C for each cysteine mutant (Cys) and wild type (WT) cPLA2α C2 domain as described in Figure 2 and methods. The Ca2+ affinity change triggered by each mutation is indicated as the ratio of [Ca2+]1/2 values for the mutant and wild-type C2 domains. Samples contained 1 μM free C2 domain, 100 mM KCl, 20 mM HEPES pH 7.4, and 5 mM DTT. The dissociation constant of the wild-type C2 domain for Ca2+ is KD = 14 ± 2 μM.
The D43C substitution yields the largest perturbation of Ca2+ binding. For this mutant, no detectable fluorescence increase is detected at Ca2+ concentrations as high as 1 mM, indicating that Ca2+ binding is no longer detectable and that modification of Asp 43 increases [Ca2+]1/2 at least 200-fold relative to the native C2 domain. Notably, Asp 43 is a bidentate ligand that simultaneously coordinates both Ca2+ ions in a bridging fashion (24). Moreover, of the five coordination mutants, Asp 43 mutant is the only one that fails to exhibit Ca2+-triggered docking to phosphatidylcholine (PC) membranes in protein-to-membrane FRET studies (data not shown). Overall, since Asp 43 is the only coordinating position at which Cys substitution eliminates detectable Ca2+ binding and fully blocks Ca2+-activated membrane docking, the results indicate that Asp 43 is the most important of the five coordinating side chains.
Smaller, but still significant, effects on Ca2+ binding are observed for the substitutions at the other two bidentate Asp positions, D40C and D93C. In the D40C mutant, modification of Asp 40 yields a 21-fold increase in [Ca2+]1/2 relative to the wild-type domain, indicating a large loss of Ca2+ affinity. In addition, the Hill coefficient decreases from 1.7 (for wild type) to 1.1, suggesting that most or all of the positive cooperativity between sites I and II is lost. Such a result is consistent with the possibility that either site I or II has been completely inactivated, such that the Ca2+-binding stoichiometry has been reduced from 2 to 1 Ca2+ ions per domain. Like the Asp 43 residue, Asp 40 is a bidentate ligand that simultaneously coordinates both Ca2+ ions in a bridging fashion (24), thereby explaining its importance to Ca2+ binding in both sites I and II. However, the smaller effect of Asp 40 modification on Ca2+ binding indicates that it is not as critical as the Asp 43 residue, and that either site I or II retains the ability to bind a single Ca2+ ion.
In the D93C mutant, modification of Asp 93 yields a 10-fold increase in [Ca2+]1/2 relative to the wild-type domain, indicating a moderate loss of Ca2+ affinity. The Hill coefficient also decreases from 1.7 (for wild type) to 0.8, suggesting the complete loss of the positive cooperativity between sites I and II. These findings are consistent with the possibility that either site I or II has been fully inactivated, thereby reducing the Ca2+-binding stoichiometry of the domain from two to one Ca2+ ions per domain. Like the two other Asp residues discussed above, Asp 93 is bidentate, but unlike the previous examples Asp 93 is not a bridging ligand. Instead, both Asp 93 carboxylate oxygens coordinate the Ca2+ ion bound in site II (24). Thus, it is site II that is most likely inactivated by the loss of Asp 93, thereby accounting for the absence of positive cooperativity.
Significant effects on Ca2+ binding are also observed for the N65C and N95C substitutions. In the N65C mutant, modification of Asn 65 increases [Ca2+]1/2 by a factor of 9-fold relative to the wild-type domain, indicating a moderate loss of affinity. The Hill coefficient of 1.4 indicates that modification of Asn 65 retains the positive cooperativity between sites I and II, and thus that the domain retains the binding of two Ca2+ ions. Unlike the coordinating Asp side chains, Asn 65 is monodentate and provides only one coordinating oxygen to the Ca2+ ion bound in site I (24), thereby explaining the smaller effects observed for this substitution.
In the final mutant N95C, modification of Asn 95 increases [Ca2+]1/2 by a factor of only 3-fold relative to wild type and retains the native Hill coefficient of 1.8. It follows that modification of this position yields the smallest effects on Ca2+ binding observed for the five coordinating side chains. Like Asn 65, the Asn 95 side chain provides monodentate coordination, but Asn 95 is a ligand to the Ca2+ in site II (24).
Together, the effects of amino acid replacement at the five coordinating side chain positions provide strong evidence that site I plays a more important role than site II in defining the structure and [Ca2+]1/2 of the cooperative binding site pair. This conclusion is supported by the observation that replacement of the monodentate Asn 95 ligand in site II has the smallest effect on Ca2+ binding, while the corresponding replacement of monodentate Asn 65 in site I causes a 3-fold larger increase in the [Ca2+]1/2. Moreover, the replacement of monodentate Asn 65 in site I causes nearly the same Ca2+ affinity loss as the replacement of bidentate Asp 93 in site II, despite the fact that the latter residue provides two coordinating oxygens. In summary, site I is more critical than site II in the binding site pair, while the bidentate, bridging Asp 43 carboxylate that coordinates the adjacent Ca2+ ions in both sites is the most important of the five side chain ligands and is essential for Ca2+ binding to both sites. The experimental results do not, however, explain why Asp 43 is more important than Asp 40, which also serves as a bidentate ligand that bridges the two Ca2+ ions. To investigate this question, pKa calculations were carried out for the three coordinating Asp side chains to investigate their electrostatic environments.
Calculation of Pseudo-pKa’s for the Coordinating Aspartates
The microscopic affinity of a given Asp carboxylate for Ca2+ will depend in part on the local electrostatic environment, which modulate the stability of the Asp negative charge. When the negative charge is destabilized by local electrostatic fields, the Asp will typically exhibit a higher affinity for Ca2+. Such a destabilized carboxylate will also exhibit higher affinity for protons; thus, knowledge of the proton affinity of the coordinating carboxylates can identify which carboxylates make the largest contributions to Ca2+ affinity. Here we focus solely on the relative cation affinities of the three coordinating carboxylates in the Ca2+-occupied state of the binding pocket. Since the relevant electrostatic environment of each coordinating carboxylate is that experienced in the Ca2+-occupied structure of the pocket, the Gedanken approach began by removing the Ca2+ ions from the crystal structure of the Ca2+-occupied C2 domain while fixing the coordinating residues in their Ca2+-binding conformations (Figure 1B). Subsquently, this pseudo-structure was used to calculate a pseudo-pKa for each coordinating carboxylate. The pseudo-pKa is different from the true pKa of each carboxylate in the apo protein, since the true pKa is defined by the fee energy change associated with protonating that carboxylate in the true structure of the apo site, which is unknown but is undoubtedly different than the pseudo-structure utilized herein. However, the pseudo-structure and its corresponding pseudo-pKa’s are useful in comparing the relative affinities of the coordinating carboxylates in the Ca2+-occupied binding pocket. Subsequently, hydrogens were added to all nontitratable moieties and protons were added to all titratable groups, including the side chain carboxylates of coordinating Asp residues 40, 43, and 93. To determine the optimal locations of the protons on titratable groups, a most-likely hydrogen-bond network was obtained by positioning protons of all Asp and Glu residues within the C2 domain using a proton-energy guided sequential protonation procedure (see Methods). For the aspartates in the Ca2+-binding pocket of the C2 domain of cPLA2α, this protocol resulted in the following relative order of protonation: first protonation of Asp43, followed by protonation of Asp40, followed by protonation of Asp93 (Asp43 → Asp40 → Asp93). The protonated model that was a result of this sequence of protonation is shown as conformer 1 in Figure 3.
Figure 3.

Modeled protonation states of the three coordinating aspartate side chains. Shown are the side chains of coordinating Asp residues 40, 43, and 93, including the optimized proton positions utilized by six separate pseudo-pKa calculations in which protons are added consecutively to each of the three carboxylates. The side chains are constrained in a pseudo-structure generated by removing the two Ca2+ ions from the crystal structure conformation of the binding pocket, while fixing the side chains in their Ca2+-binding positions. The inset table indicates the order of proton addition for each of the six protonation models, while the small numbers on each side chain indicate the proton positions used for these models.
But these three residues can also be protonated in five other possible relative orders. To generate protonated models using the five other sequences of protonation, we made the following assumption. We assumed that the titratable protons of aspartates or glutamates outside the binding site would not affect the positions of protons on these three residues. The titratable protons of Asp40, Asp43, and Asp93 were then removed from conformer 1 and the five sequences of protonation of the three aspartates were enforced (preset) to generate five separate conformers. These conformers labeled as 2, 3, 4, 5, and 6 are shown overlaid on conformer 1 in Figure 3.
The probability that these three residues would be protonated in a given order was calculated using a reduced form of eq 5. For three residues i, j and k, and for the probability that residue i is protonated before j and residue j before k, eq 5 reduces to a product of two terms
| (6) |
The probabilities that these three aspartates would be protonated in each of the six possible consecutive orders are listed in Table 2.
Table 2.
Probabilities of the Six Possible Sequences of Protonationa
| sequence of protonation | probability P(i → j → k) | resulting conformer no. |
|---|---|---|
| Asp43 → Asp40 → Asp93 | 0.46 | 1 |
| Asp43 → Asp93 → Asp40 | 0.40 | 2 |
| Asp40 → Asp43 → Asp93 | 0.06 | 3 |
| Asp40 → Asp93 → Asp43 | 0.04 | 4 |
| Asp93 → Asp40 → Asp43 | 0.02 | 5 |
| Asp93 → Asp43 → Asp40 | 0.02 | 6 |
For the three coordinating aspartates in sites I and II, the probability of each indicated protonation sequence was calculated using eq 6 (see methods). Since a given protonation sequence generates a unique set of conformational optimizations in a path-dependent fashion, each protonation sequence yields a different final conformation and hydrogen-bond network for the coordinating aspartates.
Pseudo-pKa’s were then separately calculated for each of the six protonated models assuming values for the protein dielectric constants (8, 12, and 16) that are significantly larger than those typically used for an electrostatic description of protein interiors. These moderate values of protein dielectric constant implicitly account for penetration of water into the Ca2+-binding pocket (38) and also help account for the conformational relaxation of flexible side chains (39, 40). It is important to note that these are not the dielectric constants of the protein, but are used to implicitly absorb the effects of certain phenomena that are not explicitly modeled in the calculation of pKa. The pseudo-pKa values resulting from each of the six conformers were then averaged using the probabilities listed in Table 2 as weights. The weighted averages of pseudo-pKa for different assumptions of the protein dielectric constant are listed in Table 3.
Table 3.
Averaged Pseudo-pKa Values for the Aspartates in the C2 Domain Ca2+-Binding Pocketa
| residue | weighted average of pseudo-pKa
|
||
|---|---|---|---|
| PD constant = 8 | PD constant = 12 | PD constant = 16 | |
| Asp 40 | 6.3 | 5.4 | 5.1 |
| Asp 43 | 12.0 | 9.2 | 8.4 |
| Asp 93 | 10.6 | 10.2 | 8.8 |
Calculations were carried out for indicated values of the protein dielectric (PD) constant, based on a pseudo-structure of the Ca2+-binding pocket in which the two Ca2+ ions were removed from the crystal structure of the Ca2+-occupied C2 domain (24), and titratable protons were then added using the six different sequences of protonation (Table 2). The pseudo-pKa values resulting from each of the six conformers were averaged using weights listed in Table 2.
The calculated pseudo-pKa values reveal the importance of electrostatic factors in the Ca2+-binding roles of Asp 43, Asp 40, and Asp 93. Notably, Asp 43 consistently exhibits a higher pseudo-pKa than either Asp 40 or Asp 93, indicating that the negative charge of its carboxylate is more destabilized by the local environment. Examination of the structure (24) reveals the sources of this destabilization: the Asp 43 carboxylate is more sequestered from solvent than those of Asp 40 and 93, and is within 3.5 Å of seven carboxylate and carbonyl oxygens (D40 OD1, D40 OD2, T41 O, P42 O, N65 OD1, D93 OD1, A94 O). The high pseudo-pKa of Asp 43 further indicates that it would have the highest general cation affinity of the coordinating side chains. Such a high cation affinity, plus its bridging position between sites I and II, fully explain the observation that Asp 43 is the most important Ca2+-coordinating ligand. By contrast, Asp 40, the only other bridging ligand, consistently exhibits the lowest pseudo-pKa in the calculations and thus possesses a significantly lower cation affinity than Asp 43. Thus, the different electrostatic environments of Asp 43 and Asp 40 explain the smaller contribution of the latter to Ca2+ affinity. The remaining ligand, Asp 93, is bidentate like Asp 43 and Asp 40, and it possesses a consistently higher pseudo-pKa than Asp 40 indicating a higher cation affinity. However, the observation that Asp 40 plays a greater role in defining Ca2+ affinity than Asp 93 indicates that the bridging position of Asp 40, as well as its contributions to site I, outweigh the contributions of Asp 93 to site II in the overall binding of two Ca2+ ions.
In the Ca2+-occupied site, the three coordinating Asp residues are fully deprotonated to provide bidentate coordination in sites I and II; however, the pseudo-pKa’s calculated in the absence of Ca2+ emphasize that the apo binding pocket would be partially protonated if the residues within the pocket remain fixed in their Ca2+-coordinating positions. In this case, the calculations performed for dielectric constants of 8 and 12, which are reasonable values for a ligand binding cleft within a protein, indicate that the three Asp residues would bind from 1 to 2 protons in the absence of bound cations. More likely, the coordinating side chains would relax to conformations different from their Ca2+-coordinating state to optimize their electrostatic environment of the apo binding pocket, so that the calculated number of bound protons is an upper limit. As a result, the net negative charge of the apo pocket is between −3 and −1 eu. By contrast, when the pocket is loaded with two Ca2+ ions, the three coordinating Asp residues are fully deprotonated to provide bidentate coordination, but the positive charge of the two divalent cations (+4 eu) completely cancels the coordinating negative charge (−3 eu), yielding a net positive charge of +1 eu. These findings indicate that in a cellular setting, the Ca2+-binding pocket switches from a negatively charged “off” state to a positively charged “on” state when it is loaded with two divalent cations during a Ca2+ signal. Such findings have important implications for a molecular understanding of the electrostatic switch that controls, at least in part, membrane docking.
DISCUSSION
The experimentally determined effects of coordinating side chain substitutions on Ca2+ binding to the cPLA2α C2 domain reveal the relative importance of the site I and site II coordinating residues in the binding of two Ca2+ ions. Site I plays a more important role in defining the macroscopic Ca2+ affinity, since the [Ca2+]1/2 is 3-fold more sensitive, on a per-oxygen basis, to replacement of coordinating oxygens in site I than in site II. Thus, substitution of monodentate Asn 65 in site I causes a 3-fold greater Ca2+ affinity loss than the equivalent substitution of monodentate Asn 95 in site II. Similarly, substitution of Asn 65 in site I causes a 3-fold greater affinity loss than the substitution of either of the two Asp 93 coordinating oxygens in site II, assuming that the Ca2+ affinity loss due to replacement of bidentate Asp 93 stems from equal contributions of its two coordinating oxygens. The simplest model consistent with these findings is an ordered binding model in which the first Ca2+ ion typically binds to site I and the second Ca2+ ion binds to site II, since for a cooperative binding site pair the site that loads first with ligand largely defines the apparent ligand affinity. However, because the loss of coordinating oxygens in site I and II exhibit only a modest 3-fold difference in their effects on Ca2+ affinity, it is likely that the ordered binding mechanism is not perfect, such that the first Ca2+ ion will sometimes bind first to site II rather than site I.
The findings provide the first experimental support for the hypothesis that the bridging ligands Asp 40 and 43 play an essential role in positive cooperativity (24). Loss of Asp 40 is observed to eliminate positive cooperativity, while loss of Asp 43 eliminates all detectable Ca2+ binding. A simple mechanism that explains the role of these two side chains in cooperativity begins with the apo site, wherein charge repulsion between the coordinating Asp carboxylates ensures that they are partially protonated and generally not in their Ca2+-binding orientations (37). The binding of the first Ca2+ ion, either to site I or II, drives the conformations of the bridging side chains Asp 40 and 43 into their Ca2+-binding positions. At the same time, the binding of the first Ca2+ ion partially or completely deprotonates the three Asp residues. Together these events triggered by the binding of the first Ca2+ ion prepare the structure and protonation state of the remaining site for the second Ca2+-binding event. As a result of this preordering, the second Ca2+ ion is able to bind with higher affinity than the first, accounting for the strong positive cooperativity between the two sites. The magnitude of this positive cooperativity is especially striking given the close proximity of the two Ca2+ ions, which generates considerable electrostatic repulsion between the two divalent cations. Since Ca2+ usually binds first to site I, it is primarily site I that defines the overall Ca2+ affinity, while site II usually binds the second Ca2+ ion and benefits from the preorganization provided by prior Ca2+ binding to site I.
The most important coordinating ligand is Asp 43, which is the only coordinating side chain essential for Ca2+ binding to both sites I and II. The strong contribution of Asp 43 to the Ca2+ affinity arises partly from its structural role as a bridging ligand, since it provides coordination to Ca2+ ions in both sites I and II and contributes to the positive cooperativity between the two sites. In addition, pseudo-pKa calculations carried out for the apo binding pocket with the coordinating residues fixed in their Ca2+-binding positions, indicate that the local electrostatic environment destabilizes the negative charge of the Asp 43 carboxylate, thereby substantially increasing its general cation affinity relative to the other coordinating Asp residues. This destabilization results from a more buried location as well as proximity of the Asp 43 carboxylate to seven carboxylate and carbonyl oxygens within 3.5 Å. As a result of its central importance, Asp 43 is the only one of the five coordinating side chains for which substitution completely eliminates Ca2+ binding to both sites I and II, as well as Ca2+-activated membrane docking.
Finally, the pseudo-pKa calculations for three coordinating Asp side chains in sites I and II indicate that in the absence of bound cations, with the coordinating residues fixed in their Ca2+-binding positions, at least two of the Asp side chains are partially or fully protonated. It is worth noting that this result was also provided by calculations carried out for the protonation model generated by a simultaneous protonation of all aspartates (shown as conformer 7 in Figure 3). These calculations suggest that the apo binding pocket could retain up to 1 to 2 bound protons, yielding a net charge for the pocket of −3 to −1 eu. As a result, the negative charge of the three coordinating Asp residues is not fully developed until two Ca2+ ions bind, at which point the three Asp carboxylates are fully deprotonated so that they can serve as bidentate ligands. When the binding pocket is filled with two divalent cations such as Ca2+, the net charge becomes positive at +1 eu. Thus, in a resting cell prior to a Ca2+ signal, the apo binding pocket possesses a net negative charge, and switches to a net positive charge upon Ca2+ loading. Notably, the pseudo-pKa calculations indicate that electrostatic switch models must take into account the significant protonation state of the apo C2 domain before Ca2+ binds, which reduces the magnitude of the Ca2+-triggered electrostatic change available for regulation of membrane docking. The reduced magnitude of this electrostatic switch increases the relative importance of other activation mechanisms, particularly the direct or indirect coordination of the two Ca2+ in the binding pocket by lipid headgroup oxygens upon membrane docking. Evidence supporting the essential roles of both the electrostatic switch activation mechanism and the coordinating lipid activation mechanism is now available for C2 domains, suggesting that both mechanisms contribute to Ca2+-activated membrane docking (5, 6, 14, 41–45).
To fully understand Ca2+-activated membrane docking, high-resolution structural information is needed for the Ca2+-loaded C2 domain docked to the membrane surface. Considerable information is now available regarding the structure of the protein–membrane complex formed when the cPLA2α C2 domain binds to a lipid bilayer: EPR studies have revealed the depth of C2 domain penetration into the membrane and the angle of the domain relative to the membrane surface (1, 46). However, nothing is yet known about the effects of protein insertion on local lipid structure, which must be significantly perturbed. To define the effects of protein insertion on the positions and conformations of the surrounding lipid molecules, it will again be necessary to employ both experimental and computational methods to develop a more complete molecular picture of the protein-membrane interface.
Footnotes
Support provided by NIH Grants GM R01-063235 (to J.J.F.) and GM R01-054651 (to H.L.S./E.J.), and by a DOE/GTL Grant (to E.J.).
Abbreviations: cPLA2α, the α-isoform of cytosolic phospholipase A2; PKC, protein kinase C; Syt-I, synaptotagmin I; CBL, Ca2+-binding loop; HEPES, N-(2-hydroxyethyl)piperazine-N′-2-ethanesulfonic acid.
References
- 1.Malmberg NJ, Van Buskirk DR, Falke JJ. Membrane docking loops of the cPLA2 C2 domain: Detailed structural analysis of the protein-membrane interface via site-directed spin labeling. Biochemistry. 2003;42:13227–13240. doi: 10.1021/bi035119+. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Hurley JH. Membrane proteins. Adapting to life at the interface. Chem Biol. 2003;10:2–3. doi: 10.1016/s1074-5521(03)00006-1. [DOI] [PubMed] [Google Scholar]
- 3.Hurley JH, Meyer T. Subcellular targeting by membrane lipids. Curr Opin Cell Biol. 2001;13:146–152. doi: 10.1016/s0955-0674(00)00191-5. [DOI] [PubMed] [Google Scholar]
- 4.Tomsig JL, Creutz CE. Copines: a ubiquitous family of Ca(2+)-dependent phospholipid-binding proteins. Cell Mol Life Sci. 2002;59:1467–1477. doi: 10.1007/s00018-002-8522-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kohout SC, Corbalan-Garcia S, Torrecillas A, Gomez-Fernandez JC, Falke JJ. C2 domains of protein kinase C isoforms alpha, beta, and gamma: activation parameters and calcium stoichiometries of the membrane-bound state. Biochemistry. 2002;41:11411–11424. doi: 10.1021/bi026041k. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Nalefski EA, Wisner MA, Chen JZ, Sprang SR, Fukuda M, Mikoshiba K, Falke JJ. C2 domains from different Ca2+ signaling pathways display functional and mechanistic diversity. Biochemistry. 2001;40:3089–3100. doi: 10.1021/bi001968a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Nalefski EA, Falke JJ. The C2 domain calcium-binding motif: structural and functional diversity. Protein Sci. 1996;5:2375–2390. doi: 10.1002/pro.5560051201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Cho W. Membrane targeting by C1 and C2 domains. J Biol Chem. 2001;276:32407–32410. doi: 10.1074/jbc.R100007200. [DOI] [PubMed] [Google Scholar]
- 9.Rotin D, Staub O, Haguenauer-Tsapis R. Ubiquiti-nation and endocytosis of plasma membrane proteins: role of Nedd4/Rsp5p family of ubiquitin-protein ligases. J Membr Biol. 2000;176:1–17. doi: 10.1007/s00232001079. [DOI] [PubMed] [Google Scholar]
- 10.Edwards AS, Newton AC. Regulation of protein kinase C betaII by its C2 domain. Biochemistry. 1997;36:15615–15623. doi: 10.1021/bi9718752. [DOI] [PubMed] [Google Scholar]
- 11.Sutton RB, Davletov BA, Berghuis AM, Sudhof TC, Sprang SR. Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold. Cell. 1995;80:929–938. doi: 10.1016/0092-8674(95)90296-1. [DOI] [PubMed] [Google Scholar]
- 12.Sutton RB, Sprang SR. Structure of the protein kinase Cbeta phospholipid-binding C2 domain complexed with Ca2+ Structure. 1998;6:1395–1405. doi: 10.1016/s0969-2126(98)00139-7. [DOI] [PubMed] [Google Scholar]
- 13.Shao X, Fernandez I, Sudhof TC, Rizo J. Solution structures of the Ca2+-free and Ca2+-bound C2A domain of synaptotagmin I: does Ca2+ induce a conformational change? Biochemistry. 1998;37:16106–16115. doi: 10.1021/bi981789h. [DOI] [PubMed] [Google Scholar]
- 14.Davletov B, Perisic O, Williams RL. Calcium-dependent membrane penetration is a hallmark of the C2 domain of cytosolic phospholipase A2 whereas the C2A domain of synaptotagmin binds membranes electrostatically. J Biol Chem. 1998;273:19093–19096. doi: 10.1074/jbc.273.30.19093. [DOI] [PubMed] [Google Scholar]
- 15.Xu GY, McDonagh T, Yu HA, Nalefski EA, Clark JD, Cumming DA. Solution structure and membrane interactions of the C2 domain of cytosolic phospholipase A2. J Mol Biol. 1998;280:485–500. doi: 10.1006/jmbi.1998.1874. [DOI] [PubMed] [Google Scholar]
- 16.Dessen A, Tang J, Schmidt H, Stahl M, Clark JD, Seehra J, Somers WS. Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism. Cell. 1999;97:349–360. doi: 10.1016/s0092-8674(00)80744-8. [DOI] [PubMed] [Google Scholar]
- 17.Essen LO, Perisic O, Lynch DE, Katan M, Williams RL. A ternary metal binding site in the C2 domain of phosphoinositide-specific phospholipase C-delta1. Biochemistry. 1997;36:2753–2762. doi: 10.1021/bi962466t. [DOI] [PubMed] [Google Scholar]
- 18.Nalefski EA, Slazas MM, Falke JJ. Ca2+-signaling cycle of a membrane-docking C2 domain. Biochemistry. 1997;36:12011–12008. doi: 10.1021/bi9717340. [DOI] [PubMed] [Google Scholar]
- 19.Ubach J, Zhang X, Shao X, Sudhof TC, Rizo J. Ca2+ binding to synaptotagmin: how many Ca2+ ions bind to the tip of a C2-domain? Embo J. 1998;17:3921–3930. doi: 10.1093/emboj/17.14.3921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Nalefski EA, McDonagh T, Somers W, Seehra J, Falke JJ, Clark JD. Independent folding and ligand specificity of the C2 calcium-dependent lipid binding domain of cytosolic phospholipase A2. J Biol Chem. 1998;273:1365–1372. doi: 10.1074/jbc.273.3.1365. [DOI] [PubMed] [Google Scholar]
- 21.Evans JH, Spencer DM, Zweifach A, Leslie CC. Intracellular calcium signals regulating cytosolic phospholipase A2 translocation to internal membranes. J Biol Chem. 2001;276:30150–30160. doi: 10.1074/jbc.M100943200. [DOI] [PubMed] [Google Scholar]
- 22.Clark JD, Schievella AR, Nalefski EA, Lin LL. Cytosolic phospholipase A2. J Lipid Mediat Cell Signal. 1995;12:83–117. doi: 10.1016/0929-7855(95)00012-f. [DOI] [PubMed] [Google Scholar]
- 23.Hegen M, Sun L, Uozumi N, Kume K, Goad ME, Nickerson-Nutter CL, Shimizu T, Clark JD. Cytosolic phospholipase A2alpha-deficient mice are resistant to collagen-induced arthritis. J Exp Med. 2003;197:1297–1302. doi: 10.1084/jem.20030016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Perisic O, Fong S, Lynch DE, Bycroft M, Williams RL. Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2. J Biol Chem. 1998;273:1596–1604. doi: 10.1074/jbc.273.3.1596. [DOI] [PubMed] [Google Scholar]
- 25.Kunkel TA, Roberts JD, Zakour RA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 1987;154:367–382. doi: 10.1016/0076-6879(87)54085-x. [DOI] [PubMed] [Google Scholar]
- 26.Nalefski EA, Falke JJ. Location of the membrane-docking face on the Ca2+-activated C2 domain of cytosolic phospholipase A2. Biochemistry. 1998;37:17642–17650. doi: 10.1021/bi982372e. [DOI] [PubMed] [Google Scholar]
- 27.Hooft RW, Sander C, Vriend G. Positioning hydrogen atoms by optimizing hydrogen-bond networks in protein structures. Proteins. 1996;26:363–376. doi: 10.1002/(SICI)1097-0134(199612)26:4<363::AID-PROT1>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
- 28.Nielsen JE, Vriend G. Optimizing the hydrogen-bond network in Poisson–Boltzmann equation-based pK(a) calculations. Proteins. 2001;43:403–412. doi: 10.1002/prot.1053. [DOI] [PubMed] [Google Scholar]
- 29.Alexov EG, Gunner MR. Incorporating protein conformational flexibility into the calculation of pH-dependent protein properties. Biophys J. 1997;72:2075–2093. doi: 10.1016/S0006-3495(97)78851-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Madura JD, Briggs JM, Wade RC, Davis RC, Luty BA, Ilin A, Antosiewicz J, Gilson MK, Bagheri B, Scott LR, McCammon JA. Electrostatics and Diffusion of Molecules in Solution: Simulations with the University of Houston Brownian Dynamics Program. Comput Phys Commun. 1995;91:57–95. [Google Scholar]
- 31.Sitkoff D, Sharp K, Honig BH. Accurate Calculation of Hydration Free Energies Using Macroscopic Solvent Models. J Phys Chem. 1994;98:1978–1988. [Google Scholar]
- 32.Richards FM. Areas, volumes, packing and protein structure. Annu Rev Biophys Bioeng. 1977;6:151–176. doi: 10.1146/annurev.bb.06.060177.001055. [DOI] [PubMed] [Google Scholar]
- 33.Antosiewicz J, McCammon JA, Gilson MK. Prediction of pH-dependent properties of proteins. J Mol Biol. 1994;238:415–436. doi: 10.1006/jmbi.1994.1301. [DOI] [PubMed] [Google Scholar]
- 34.Antosiewicz J, McCammon JA, Gilson MK. The determinants of pKa’s in proteins. Biochemistry. 1996;35:7819–7833. doi: 10.1021/bi9601565. [DOI] [PubMed] [Google Scholar]
- 35.Varma S, Jakobsson E. Ionization states of residues in OmpF and Mutants: Effects of Dielectric Constant & Interactions between Residues. Biophys J. 2004;86:690–704. doi: 10.1016/S0006-3495(04)74148-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Jorgensen WL, Tirado-Rives J. The OPLS potential functions for proteins: energy minimizations for crystals for cyclic peptides and crambin. J Am Chem Soc. 1988;110:1657–1666. doi: 10.1021/ja00214a001. [DOI] [PubMed] [Google Scholar]
- 37.Falke JJ, Drake SK, Hazard AL, Peersen OB. Molecular tuning of ion binding to calcium signaling proteins. Q Rev Biophys. 1994;27:219–290. doi: 10.1017/s0033583500003012. [DOI] [PubMed] [Google Scholar]
- 38.Dwyer JJ, Gittis AG, Karp DA, Lattman EE, Spencer DS, Stites WE, Garcia-Moreno EB. High apparent dielectric constants in the interior of a protein reflect water penetration. Biophys J. 2000;79:1610–1620. doi: 10.1016/S0006-3495(00)76411-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sham YY, Muegge I, Warshel A. The effect of protein relaxation on charge–charge interactions and dielectric constants of proteins. Biophys J. 1998;74:1744–1753. doi: 10.1016/S0006-3495(98)77885-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Schutz CN, Warshel A. What are the dielectric “constants” of proteins and how to validate electrostatic models? Proteins. 2001;44:400–417. doi: 10.1002/prot.1106. [DOI] [PubMed] [Google Scholar]
- 41.Murray D, Honig B. Electrostatic control of the membrane targeting of C2 domains. Mol Cell. 2002;9:145–154. doi: 10.1016/s1097-2765(01)00426-9. [DOI] [PubMed] [Google Scholar]
- 42.Verdaguer N, Corbalan-Garcia S, Ochoa WF, Fita I, Gomez-Fernandez JC. Ca(2+) bridges the C2 membrane-binding domain of protein kinase Calpha directly to phosphati-dylserine. Embo J. 1999;18:6329–6338. doi: 10.1093/emboj/18.22.6329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Conesa-Zamora P, Lopez-Andreo MJ, Gomez-Fernandez JC, Corbalan-Garcia S. Identification of the phos-phatidylserine binding site in the C2 domain that is important for PKC alpha activation and in vivo cell localization. Biochemistry. 2001;40:13898–13905. doi: 10.1021/bi011303o. [DOI] [PubMed] [Google Scholar]
- 44.Ochoa WF, Corbalan-Garcia S, Eritja R, Rodriguez-Alfaro JA, Gomez-Fernandez JC, Fita I, Verdaguer N. Additional binding sites for anionic phospholipids and calcium ions in the crystal structures of complexes of the C2 domain of protein kinase calpha. J Mol Biol. 2002;320:277–291. doi: 10.1016/S0022-2836(02)00464-3. [DOI] [PubMed] [Google Scholar]
- 45.Bolsover SR, Gomez-Fernandez JC, Corbalan-Garcia S. Role of the Ca2+/phosphatidylserine binding region of the C2 domain in the translocation of protein kinase Calpha to the plasma membrane. J Biol Chem. 2003;278:10282–10290. doi: 10.1074/jbc.M212145200. [DOI] [PubMed] [Google Scholar]
- 46.Frazier AA, Wisner MA, Malmberg NJ, Victor KG, Fanucci GE, Nalefski EA, Falke JJ, Cafiso DS. Membrane orientation and position of the C2 domain from cPLA2 by site-directed spin labeling. Biochemistry. 2002;41:6282–6292. doi: 10.1021/bi0160821. BI0482405. [DOI] [PubMed] [Google Scholar]

